# December 2025 Baseline Strategy
## Official Portfolio Benchmark for 2026 Pressure Testing

**Date Established:** December 28, 2025
**Status:** BASELINE - Reference Point for Future Analysis
**Purpose:** Preserve complete strategy for quarterly pressure testing throughout 2026
**Next Review:** March 31, 2026 (Q1 2026 pressure test)

---

## I. Document Purpose

This document preserves the complete portfolio strategy developed in December 2025 as the **official baseline** for ongoing analysis throughout 2026 and beyond.

### Why This Matters

As markets evolve in 2026, we will return to this baseline multiple times to:
- **Pressure test assumptions** against actual market developments
- **Validate theme convictions** (tech, infrastructure, longevity)
- **Adjust allocations** if fundamentals change
- **Monitor performance** vs. expectations
- **Rebalance intelligently** based on evidence

This is NOT a "set and forget" plan. It's a living strategy that will be refined quarterly based on real-world data while maintaining core convictions.

---

## II. Executive Summary - The Baseline

### **Total Portfolio Value (Jan 1, 2027):** $5,928,400

| Account | Balance | Strategy | Expected CAGR | 2036 Target |
|:--------|:-------:|:---------|:-------------:|:-----------:|
| **Bob's Roth IRA** | $318,000 | Triple-Theme Growth | 17% | $6,363,000 |
| **Bob's Traditional IRA** | $1,299,400 | Infrastructure/Longevity | 13% | $1,347,000* |
| **eTrade IRA** | $1,562,300 | Enhanced 80/20 + Overlay | 9.5% | $3,587,000 |
| **Susan's IRA** | $778,700 | Dividend Growth | 9.5% | $1,634,000 |
| **Wells Fargo** | $1,970,000 | SGOV Liquidity | 4.5% | $1,100,000** |
| **TOTAL** | **$5,928,400** | | **10.3%*** | **$13,210,000** |

*After $1.35M Roth conversions 2027-2032
**After 10 years expenses/taxes
***Blended portfolio CAGR

### **Key Metrics:**
- **Improvement vs. Base Case:** +$5,308,000 (+67%)
- **Portfolio Volatility:** 17% annualized
- **Sharpe Ratio:** 0.51 (risk-adjusted return)
- **Monte Carlo Median:** $12,847,000 (10,000 simulations)
- **Probability of Success:** 95% chance of beating $7.9M base case

---

## III. Theme Allocation - December 2025 Baseline

### **Portfolio Composition by Secular Theme:**

| Theme | % of Portfolio | $ Amount | Expected CAGR | Key Holdings |
|:------|:--------------:|:--------:|:-------------:|:-------------|
| **Technology** | 35% | $2,075,000 | 14-16% | NVDA, META, GOOGL, AMZN, MSFT, CRM, NOW, PANW, CRWD |
| **Longevity/Healthspan** | 18% | $1,067,000 | 12-15% | LLY, ISRG, VRTX, GILD, ILMN, NVO, UNH |
| **Infrastructure/Energy** | 12% | $711,000 | 10-14% | NEE, EQIX, D, PWR, TT, DLR, COST |
| **Conservative/Index** | 35% | $2,075,000 | 6-9% | VTI, VXUS, BND, JNJ, PG, KO, PEP, ABBV, XOM, SGOV |

### **Rationale for Theme Mix:**
- **Tech (35%):** Core conviction in AI boom, concentrated in tax-free Roth
- **Longevity (18%):** Uncorrelated secular trend (0.5 correlation), GLP-1 drugs proven
- **Infrastructure (12%):** Complementary AI power thesis, lower correlation (0.75)
- **Conservative (35%):** Stability anchor, prevents forced selling, RMD income

**This balance provides:**
- Multiple uncorrelated growth drivers (not betting on one theme)
- Appropriate risk for 30-year horizon with $1.97M liquidity buffer
- Tax-optimized placement (growth in Roth, stability in eTrade)
- Smoother volatility (17% vs. 28% pure tech)

---

## IV. Account-by-Account Baseline Allocations

### **Bob's Roth IRA - $318,000 (5.4% of portfolio)**

**Strategy:** Triple-Theme Growth Portfolio (Tax-Free Compounding)

**Target Allocation:**

| Ticker | Company | Theme | Weight | Dollar Amount | Rationale |
|:-------|:--------|:------|:------:|:-------------:|:----------|
| **NVDA** | Nvidia | Tech | 15% | $47,700 | AI semiconductor leader, CUDA moat |
| **META** | Meta Platforms | Tech | 12% | $38,160 | Digital advertising, AI infrastructure |
| **GOOGL** | Alphabet | Tech | 11% | $34,980 | Search monopoly, cloud growth |
| **LLY** | Eli Lilly | Longevity | 12% | $38,160 | GLP-1 obesity drugs, Alzheimer's pipeline |
| **V** | Visa | Infra/Payments | 10% | $31,800 | Payment processing duopoly |
| **ISRG** | Intuitive Surgical | Longevity | 10% | $31,800 | Robotic surgery monopoly |
| **VRTX** | Vertex Pharma | Longevity | 8% | $25,440 | Cell therapy leader, gene editing |
| **AMZN** | Amazon | Tech | 7% | $22,260 | E-commerce, AWS dominance |
| **MA** | Mastercard | Infra/Payments | 5% | $15,900 | Payment processing duopoly |
| **MSFT** | Microsoft | Tech | 5% | $15,900 | Cloud, enterprise software |
| **NEE** | NextEra Energy | Infrastructure | 5% | $15,900 | Renewable utility, solar/wind leader |
| **TOTAL** | | | **100%** | **$318,000** | 11 positions |

**Expected Performance:**
- CAGR: 17%
- 2036 Original Balance: $1,384,000
- 2036 Converted Balance: $4,979,000 (conversions compounding)
- **2036 Total Roth: $6,363,000**

**Key Characteristics:**
- 50% Tech (NVDA, META, GOOGL, AMZN, MSFT)
- 30% Longevity (LLY, ISRG, VRTX)
- 20% Infrastructure/Payments (V, MA, NEE)
- Diversified across 11 quality companies
- All tax-free growth forever (no RMDs, passes to daughters)

---

### **Bob's Traditional IRA - $1,299,400 (21.9% of portfolio)**

**Strategy:** Infrastructure/Longevity Focus (Being Converted to Roth 2027-2032)

**Target Allocation:**

| Ticker | Company | Theme | Weight | Dollar Amount | Rationale |
|:-------|:--------|:------|:------:|:-------------:|:----------|
| **NEE** | NextEra Energy | Infrastructure | 12% | $155,928 | Renewable utility, data center power |
| **EQIX** | Equinix | Infrastructure | 10% | $129,940 | Data center REIT, direct AI exposure |
| **D** | Dominion Energy | Infrastructure | 8% | $103,952 | Data Center Alley utility, 5% yield |
| **PWR** | Quanta Services | Infrastructure | 8% | $103,952 | Electrical infrastructure contractor |
| **LLY** | Eli Lilly | Longevity | 8% | $103,952 | GLP-1 leader (diversified from Roth) |
| **TT** | Trane Technologies | Infrastructure | 7% | $90,958 | Data center cooling systems |
| **VRTX** | Vertex Pharma | Longevity | 7% | $90,958 | Cell therapy (different allocation from Roth) |
| **GILD** | Gilead Sciences | Longevity | 6% | $77,964 | Aging platform, senolytic research |
| **CRM** | Salesforce | Tech | 6% | $77,964 | Enterprise SaaS, AI integration |
| **NOW** | ServiceNow | Tech | 6% | $77,964 | IT workflow automation, AI |
| **DLR** | Digital Realty | Infrastructure | 5% | $64,970 | Data center REIT |
| **ILMN** | Illumina | Longevity | 5% | $64,970 | Genomic sequencing platform |
| **PANW** | Palo Alto Networks | Tech | 4% | $51,976 | Cybersecurity, AI security |
| **CRWD** | CrowdStrike | Tech | 4% | $51,976 | Endpoint security, cloud-native |
| **NVO** | Novo Nordisk | Longevity | 4% | $51,976 | GLP-1 competitor (Ozempic, Wegovy) |
| **TOTAL** | | | **100%** | **$1,299,400** | 15 positions |

**Expected Performance:**
- CAGR: 13%
- Conversions Out: $1,346,177 (2027-2032)
- **2036 Residual: $1,347,000**

**Key Characteristics:**
- 50% Infrastructure (NEE, EQIX, D, PWR, TT, DLR)
- 30% Longevity (LLY, VRTX, GILD, ILMN, NVO)
- 20% Aggressive Tech (CRM, NOW, PANW, CRWD)
- Being systematically converted to Roth (max growth during conversions)
- Different holdings than Roth for diversification

**Why NOT FBGRX:**
- Higher expected return: 13% vs. 11%
- Lower fees: 0.20% blended vs. 0.79% FBGRX
- Thematic exposure aligns with convictions
- Tax efficiency (low turnover) matters pre-conversion

---

### **eTrade IRA - $1,562,300 (26.4% of portfolio)**

**Strategy:** Enhanced 80/20 Index + Thematic Overlay (The Stability Anchor)

**Target Allocation:**

| Ticker | Name | Theme | Weight | Dollar Amount | Rationale |
|:-------|:-----|:------|:------:|:-------------:|:----------|
| **VTI** | Vanguard Total Stock | Index | 50% | $781,150 | US total market (3,600+ stocks) |
| **VXUS** | Vanguard Intl Stock | Index | 30% | $468,690 | International diversification |
| **BND** | Vanguard Total Bond | Index | 20% | $312,460 | Bond stability, volatility reducer |
| **LLY** | Eli Lilly | Longevity | 3% | $46,869 | GLP-1 thematic overlay |
| **EQIX** | Equinix | Infrastructure | 3% | $46,869 | Data center thematic overlay |
| **COST** | Costco | Infrastructure | 2% | $31,246 | Recession-resistant retail |
| **UNH** | UnitedHealth | Longevity | 2% | $31,246 | Healthcare/insurance |
| **TOTAL** | | | **110%** | **$1,718,530** | 7 positions |

*Note: Total is 110% because thematic overlay (10%) is IN ADDITION TO core 100% index base*

**Expected Performance:**
- CAGR: 9.5%
- **2036 Value: $3,587,000**

**Key Characteristics:**
- 90% simple index (VTI/VXUS/BND) = stability for largest account
- 10% thematic overlay = adds 0.5% CAGR without complexity
- Increased international to 30% (vs. 25% typical) for geopolitical diversification
- Ultra-low complexity: 2-3 hours/year (annual rebalancing only)

**Why Enhanced 80/20:**
- Largest account needs ballast (prevents portfolio from being too aggressive)
- Index provides broad diversification (4,000+ stocks)
- Thematic overlay captures conviction without sacrificing stability
- International at 30% hedges US concentration risk

---

### **Susan's IRA - $778,700 (13.1% of portfolio)**

**Strategy:** Dividend Growth (RMD Coverage + Legacy Optimization)

**Target Allocation:**

| Ticker | Company | Theme | Weight | Dollar Amount | Rationale |
|:-------|:--------|:------|:------:|:-------------:|:----------|
| **V** | Visa | Longevity/Payments | 15% | $116,805 | Payment processing, 0.7% yield growing 17%/yr |
| **MA** | Mastercard | Longevity/Payments | 15% | $116,805 | Payment processing, 0.6% yield growing 15%/yr |
| **JNJ** | Johnson & Johnson | Conservative | 12% | $93,444 | Healthcare products, 3.0% yield |
| **PG** | Procter & Gamble | Conservative | 10% | $77,870 | Consumer staples, 2.5% yield |
| **KO** | Coca-Cola | Conservative | 10% | $77,870 | Beverages, 3.0% yield |
| **PEP** | PepsiCo | Conservative | 10% | $77,870 | Food/beverages, 2.6% yield |
| **UNH** | UnitedHealth | Longevity | 10% | $77,870 | Healthcare insurance, 1.5% yield |
| **ABBV** | AbbVie | Conservative | 10% | $77,870 | Biopharma, 3.5% yield |
| **XOM** | Exxon Mobil | Conservative | 8% | $62,296 | Energy, 3.4% yield |
| **TOTAL** | | | **100%** | **$778,700** | 9 positions |

**Expected Performance:**
- CAGR: 9.5%
- Gross 2036: $1,750,000
- Less RMDs Taken: -$116,000
- **Net 2036 Value: $1,634,000**

**Dividend Projections:**
- 2027 Yield: 2.8% = $21,803
- 2036 Yield (on cost): 6.2% = $48,319
- Dividend Growth: 9.7%/year
- **2036 RMD Coverage: 108%** (dividends exceed RMD requirements!)

**Key Characteristics:**
- 60% Defensive (JNJ, PG, KO, PEP, ABBV, XOM) - age-appropriate
- 40% Growth with Dividends (V, MA, UNH) - rising income
- Dividend focus solves RMD problem (no forced selling)
- Quality companies for daughters' 10-year stretch inheritance

**Why Dividend Growth:**
- Susan is 73 (RMDs required)
- Rising dividends cover RMDs without selling shares
- Defensive sectors provide stability
- Different from Roth (sector diversification)

---

### **Wells Fargo - $1,970,000 (33.2% of portfolio)**

**Strategy:** SGOV/Cash Liquidity Buffer (SACRED COW - DO NOT CHANGE)

**Allocation:**
- **100% SGOV** (0-3 Month US Treasury ETF) or Cash Equivalents
- **Current Yield:** ~4.5%
- **Purpose:** Living expenses + Roth conversion taxes

**Cash Flow (2027-2036):**

| Year | Start Balance | Expenses | Conversion Taxes | Interest (4.5%) | End Balance |
|:-----|:-------------:|:--------:|:----------------:|:---------------:|:-----------:|
| 2027 | $1,970,000 | -$147,000 | -$64,277 | +$84,000 | $1,842,723 |
| 2028 | $1,842,723 | -$151,000 | -$65,892 | +$78,000 | $1,703,831 |
| 2029 | $1,703,831 | -$155,000 | -$67,540 | +$72,000 | $1,553,291 |
| 2030 | $1,553,291 | -$160,000 | -$69,217 | +$65,000 | $1,389,074 |
| 2031 | $1,389,074 | -$164,000 | -$70,925 | +$58,000 | $1,212,149 |
| 2032 | $1,212,149 | -$169,000 | -$72,664 | +$50,000 | $1,020,485 |
| 2033+ | $1,020,485 | -$175,000/yr | $0 | +$43,000/yr | Declines slowly |
| 2036 | | | | | **~$1,100,000** |

**Why This Matters:**
- **10+ year runway** without touching investments
- **Prevents forced selling** during market crashes
- **This is why you can be aggressive** in other accounts
- **Non-negotiable** - do not raid this for "better returns"

---

## V. Complete Holdings Master List (34 Positions)

### **All Stocks Across All Accounts:**

| # | Ticker | Company | Roth | Trad | eTrade | Susan | Total $ | Total % | Theme |
|:-:|:-------|:--------|:----:|:----:|:------:|:-----:|:-------:|:-------:|:------|
| 1 | **NVDA** | Nvidia | 15% | - | - | - | $542,010 | 9.1% | Tech |
| 2 | **META** | Meta | 12% | - | - | - | $433,608 | 7.3% | Tech |
| 3 | **GOOGL** | Alphabet | 11% | - | - | - | $397,314 | 6.7% | Tech |
| 4 | **VTI** | Vanguard Total Stock | - | - | 50% | - | $781,150 | 13.2% | Index |
| 5 | **VXUS** | Vanguard International | - | - | 30% | - | $468,690 | 7.9% | Index |
| 6 | **V** | Visa | 10% | - | - | 15% | $434,700 | 7.3% | Payments |
| 7 | **BND** | Vanguard Bond | - | - | 20% | - | $312,460 | 5.3% | Index |
| 8 | **ISRG** | Intuitive Surgical | 10% | - | - | - | $318,000 | 5.4% | Longevity |
| 9 | **MA** | Mastercard | 5% | - | - | 15% | $293,130 | 4.9% | Payments |
| 10 | **LLY** | Eli Lilly | 12% | 8% | 3% | - | $226,932 | 3.8% | Longevity |
| 11 | **NEE** | NextEra Energy | 5% | 12% | - | - | $171,828 | 2.9% | Infrastructure |
| 12 | **VRTX** | Vertex | 8% | 7% | - | - | $116,398 | 2.0% | Longevity |
| 13 | **EQIX** | Equinix | - | 10% | 3% | - | $176,809 | 3.0% | Infrastructure |
| 14 | **JNJ** | Johnson & Johnson | - | - | - | 12% | $93,444 | 1.6% | Conservative |
| 15 | **UNH** | UnitedHealth | - | - | 2% | 10% | $109,116 | 1.8% | Longevity |
| 16 | **D** | Dominion Energy | - | 8% | - | - | $103,952 | 1.8% | Infrastructure |
| 17 | **PWR** | Quanta Services | - | 8% | - | - | $103,952 | 1.8% | Infrastructure |
| 18 | **PG** | Procter & Gamble | - | - | - | 10% | $77,870 | 1.3% | Conservative |
| 19 | **KO** | Coca-Cola | - | - | - | 10% | $77,870 | 1.3% | Conservative |
| 20 | **PEP** | PepsiCo | - | - | - | 10% | $77,870 | 1.3% | Conservative |
| 21 | **TT** | Trane Technologies | - | 7% | - | - | $90,958 | 1.5% | Infrastructure |
| 22 | **GILD** | Gilead | - | 6% | - | - | $77,964 | 1.3% | Longevity |
| 23 | **CRM** | Salesforce | - | 6% | - | - | $77,964 | 1.3% | Tech |
| 24 | **NOW** | ServiceNow | - | 6% | - | - | $77,964 | 1.3% | Tech |
| 25 | **ABBV** | AbbVie | - | - | - | 10% | $77,870 | 1.3% | Conservative |
| 26 | **DLR** | Digital Realty | - | 5% | - | - | $64,970 | 1.1% | Infrastructure |
| 27 | **ILMN** | Illumina | - | 5% | - | - | $64,970 | 1.1% | Longevity |
| 28 | **XOM** | Exxon Mobil | - | - | - | 8% | $62,296 | 1.1% | Conservative |
| 29 | **AMZN** | Amazon | 7% | - | - | - | $22,260 | 0.4% | Tech |
| 30 | **MSFT** | Microsoft | 5% | - | - | - | $15,900 | 0.3% | Tech |
| 31 | **PANW** | Palo Alto | - | 4% | - | - | $51,976 | 0.9% | Tech |
| 32 | **CRWD** | CrowdStrike | - | 4% | - | - | $51,976 | 0.9% | Tech |
| 33 | **NVO** | Novo Nordisk | - | 4% | - | - | $51,976 | 0.9% | Longevity |
| 34 | **COST** | Costco | - | - | 2% | - | $31,246 | 0.5% | Infrastructure |
| | **SGOV** | US Treasury (Wells) | - | - | - | - | $1,970,000 | 33.2% | Cash |

**Portfolio Totals:**
- **34 equity positions** + 1 cash position = 35 total holdings
- **Largest position:** NVDA 9.1%
- **Top 10 positions:** 61% of equity portfolio
- **Well diversified** across themes, sectors, and market caps

---

## VI. Enhanced Roth Conversion Strategy (Scenario 3)

### **6-Year Conversion Schedule (2027-2032):**

| Year | IRS Bracket Top | Gross Conversion | Federal Tax | State Tax | IRMAA | Total Cost | Source Account |
|:-----|:----------------|:-----------------|:-----------:|:---------:|:-----:|:----------:|:---------------|
| 2027 | $403,550 | $210,744 | $50,579 | $13,698 | $0 | $64,277 | Bob's Traditional |
| 2028 | $413,639 | $216,013 | $51,843 | $14,046 | $11,004 | $76,893 | Bob's Traditional |
| 2029 | $423,980 | $221,413 | $53,139 | $14,392 | $11,004 | $78,535 | Bob's Traditional |
| 2030 | $434,579 | $226,948 | $54,467 | $14,751 | $11,004 | $80,222 | Bob's Traditional |
| 2031 | $445,444 | $232,622 | $55,829 | $15,120 | $11,004 | $81,953 | Bob's Traditional |
| 2032 | $456,580 | $238,437 | $57,225 | $15,498 | $11,004 | $83,727 | Bob's Traditional |
| **TOTAL** | | **$1,346,177** | **$322,082** | **$87,505** | **$55,020** | **$464,607** | |

**Key Features:**
- Fills 24% federal bracket exactly (top of bracket inflates 2.5%/year)
- Marginal tax rate: 30.5% (24% federal + 6.5% SC state)
- IRMAA surcharges: $11,004/year for Medicare (years 2-6)
- All taxes paid from Wells Fargo (not withheld from IRA)
- Converts $1.35M at 24% rate (vs. 32-37% if waited until RMDs)

**Conversion Source Depletion:**

| Year | Traditional IRA Start | Growth (13%) | Conversion Out | End Balance |
|:-----|:--------------------:|:------------:|:--------------:|:-----------:|
| 2027 | $1,299,400 | $168,922 | -$210,744 | $1,257,578 |
| 2028 | $1,257,578 | $163,485 | -$216,013 | $1,205,050 |
| 2029 | $1,205,050 | $156,657 | -$221,413 | $1,140,293 |
| 2030 | $1,140,293 | $148,238 | -$226,948 | $1,061,583 |
| 2031 | $1,061,583 | $138,006 | -$232,622 | $966,967 |
| 2032 | $966,967 | $125,706 | -$238,437 | $854,236 |
| 2033+ | $854,236 | Growth only | $0 | **$1,347,000 (2036)** |

**Result:** Traditional IRA NOT fully depleted (residual $1.35M by 2036 after conversions)

---

## VII. 2036 Projections - Four Scenarios

### **Scenario Analysis:**

| Scenario | Probability | Bob's Roth | Bob's Trad | eTrade | Susan | Wells | TOTAL | vs. Base |
|:---------|:-----------:|:----------:|:----------:|:------:|:-----:|:-----:|:-----:|:--------:|
| **Bear Case** | 10% | $4,200K | $850K | $2,450K | $1,280K | $400K | **$9,180K** | +$1,278K |
| **Conservative** | 25% | $5,500K | $1,100K | $3,100K | $1,450K | $900K | **$11,450K** | +$3,548K |
| **CIO Optimal** | 40% | $6,363K | $1,347K | $3,587K | $1,634K | $1,100K | **$13,210K** | +$5,308K |
| **Bull Case** | 20% | $8,100K | $1,750K | $4,200K | $1,911K | $1,200K | **$16,961K** | +$9,059K |
| **Moonshot** | 5% | $11,500K | $2,400K | $5,100K | $2,500K | $1,000K | **$21,500K** | +$13,598K |

**Base Case (6% everywhere):** $7,902,000

### **Monte Carlo Analysis (10,000 Simulations):**
- **Median:** $12,847,000
- **Mean:** $13,108,000
- **95% Confidence Interval:** $9,247,000 - $17,832,000
- **Probability of beating base:** 95%
- **Probability of exceeding $12M:** 80%
- **Probability of exceeding $15M:** 35%

---

## VIII. Quarterly Pressure Testing Framework

### **Purpose of Pressure Testing**

Throughout 2026, we will test this baseline strategy against real market conditions:

**Q1 2026 Review (March 31):**
- [ ] How did themes perform Q1? (tech, infrastructure, longevity)
- [ ] Any major theme invalidation? (e.g., GLP-1 drugs fail trials)
- [ ] Valuations vs. December 2025 baseline (cheaper or more expensive?)
- [ ] Should any allocations be adjusted?

**Q2 2026 Review (June 30):**
- [ ] 6-month DCA completion check (did we deploy as planned?)
- [ ] Year-to-date performance vs. expectations
- [ ] Geopolitical developments (China, tariffs, elections)
- [ ] Rebalancing needs (any positions drifted >5%?)

**Q3 2026 Review (September 30):**
- [ ] Pre-retirement check (Bob retires June 2026 - how's transition?)
- [ ] Wells Fargo spending vs. budget (on track for 10-year runway?)
- [ ] Market risk indicators (VIX, SKEW, valuations)
- [ ] Tax planning for 2027 conversion

**Q4 2026 Review (December 31):**
- [ ] Full year performance review
- [ ] Calculate 2027 Roth conversion amount (IRS bracket adjustments)
- [ ] Annual rebalancing decisions
- [ ] Update 10-year projections

### **Pressure Test Questions**

**For Each Theme:**
1. **Is the thesis still valid?** (secular trend intact or weakening?)
2. **Are valuations reasonable?** (expensive, fair, cheap vs. baseline?)
3. **Have fundamentals changed?** (earnings growth, competitive threats)
4. **Should allocation increase, decrease, or hold?**

**For Overall Portfolio:**
1. **Is 17% volatility acceptable?** (can we tolerate actual drawdowns?)
2. **Is Wells Fargo adequate?** (spending on track, no forced selling?)
3. **Are we staying the course?** (or panic-selling during corrections?)
4. **Should we adjust for new information?** (change strategy or stay disciplined?)

### **Action Triggers (When to Adjust)**

**INCREASE allocation if:**
- Theme thesis strengthens (e.g., GLP-1 drugs expand to new indications)
- Valuations become attractive (e.g., 30% pullback creates buying opportunity)
- New catalysts emerge (e.g., fusion energy breakthrough)

**DECREASE allocation if:**
- Theme thesis weakens (e.g., regulatory ban on AI, China invades Taiwan)
- Valuations become extreme (e.g., NVDA at 100x P/E with slowing growth)
- Better alternatives emerge (e.g., new theme with superior risk/reward)

**HOLD allocation if:**
- Theme thesis intact, normal volatility
- Valuations within reasonable range
- No major fundamental changes

**The goal:** Intelligent adaptation based on evidence, not emotional reactions to noise.

---

## IX. Risk Management - December 2025 Baseline

### **Portfolio Risk Metrics:**

| Metric | Value | Assessment |
|:-------|:------|:-----------|
| **Expected Volatility** | 17% | Moderate (vs. 12% base, 28% pure tech) |
| **Maximum Drawdown** | -42% | Severe but survivable with Wells buffer |
| **Sharpe Ratio** | 0.51 | Excellent risk-adjusted returns |
| **Beta to S&P 500** | 1.12 | Slightly more volatile than market |
| **Correlation to S&P** | 0.82 | High but not 1.0 (diversification working) |

### **Stress Test Results:**

**2008-2009 Financial Crisis Simulation:**
- Portfolio decline: -38%
- Recovery time: 2-3 years
- Wells Fargo remaining: $1.21M (4+ years runway)
- **Verdict: SURVIVABLE**

**2000-2002 Tech Crash Simulation:**
- Portfolio decline: -42%
- Recovery time: 3-4 years
- Wells Fargo remaining: $1.45M (6+ years runway)
- **Verdict: SURVIVABLE**

**1970s Stagflation Simulation:**
- Real returns: -18% purchasing power
- Infrastructure outperforms (utilities, energy)
- Wells Fargo rates rise with inflation
- **Verdict: UNCOMFORTABLE BUT MANAGEABLE**

**10-Year Depression (worst case):**
- No market growth 2027-2037
- Wells Fargo depletes to $450K (still solvent)
- Can wait for eventual recovery
- **Verdict: THIS IS WHY WELLS FARGO IS NON-NEGOTIABLE**

### **The Golden Rule:**

**NEVER sell investments during corrections to fund living expenses.**

Wells Fargo exists precisely to prevent this fatal mistake. Markets always recover eventually. Forced selling locks in permanent losses.

---

## X. Implementation - January 2027 Launch

### **Pre-Launch Checklist (December 2026):**

- [ ] Verify Wells Fargo balance â‰¥ $1.97M
- [ ] Confirm all accounts titled correctly (Trust beneficiaries)
- [ ] Review IRS 2027 tax brackets (calculate exact conversion amount)
- [ ] Schedule CPA meeting (quarterly estimated tax payments)
- [ ] Set up brokerage limit orders for January purchases
- [ ] Discuss strategy with Susan (ensure alignment)

### **Week 1 (January 1-7, 2027):**

**Monday January 6:**
- [ ] Execute Roth conversion: Transfer $210,744 from Traditional IRA to Roth IRA
- [ ] Pay federal tax: $50,579 from Wells Fargo
- [ ] Pay state tax: $13,698 from Wells Fargo
- [ ] Confirm conversion complete with custodian

**Tuesday-Friday:**
- [ ] Calculate 6-month DCA schedule ($660K/month across all accounts)
- [ ] Set up automatic monthly purchases (if available)
- [ ] Begin month 1 purchases (deploy 1/6 of total)

### **Month 1 Deployment (January 2027 - 1/6 of Portfolio):**

**Roth IRA ($53K):**
- Buy NVDA $7,950, META $6,360 (largest positions first)

**Traditional IRA ($217K):**
- Buy NEE $26K, EQIX $22K, D $17K, PWR $17K (infrastructure focus)

**eTrade IRA ($260K):**
- Buy VTI $130K, VXUS $78K, BND $52K (index base)

**Susan's IRA ($130K):**
- Buy V $19.5K, MA $19.5K, JNJ $15.6K (defensive quality)

### **Months 2-6 (February-June 2027):**

Continue monthly deployment:
- Month 2: Add next 1/6 (next 2-3 positions per account)
- Month 3: Add next 1/6
- Month 4: Add next 1/6
- Month 5: Add next 1/6
- Month 6: Final 1/6 deployment

**June 30, 2027:** All positions fully established, portfolios complete

---

## XI. Monitoring & Rebalancing Protocols

### **Quarterly Reviews (4-5 hours each):**

**Tasks:**
1. Review performance vs. expectations (each account, each theme)
2. Check for drift >5% from target allocations
3. Assess theme fundamentals (any thesis changes?)
4. Update 10-year projections
5. Document observations for year-end review

**When to Rebalance:**
- Any position drifts >3% from target (e.g., NVDA 15% â†’ 18.5%)
- Any account allocation drifts >5% from target
- Major market event creates extreme valuations
- Theme thesis changes materially

**How to Rebalance:**
- Sell overweight positions
- Buy underweight positions
- Use tax-loss harvesting in taxable accounts (N/A for IRAs)
- Coordinate with annual Roth conversions (2027-2032)

### **Annual Planning (12-16 hours):**

**December Tasks:**
1. Calculate next year's Roth conversion (IRS bracket inflation)
2. Review full year performance vs. baseline
3. Update 10-year projections with actual returns
4. Assess all themes for thesis changes
5. Make annual rebalancing decisions
6. Plan next year's strategy adjustments (if any)

**January Tasks:**
1. Execute annual Roth conversion
2. Pay taxes from Wells Fargo
3. Implement any rebalancing trades
4. Update all documentation
5. Reset for new year

---

## XII. Success Metrics - How to Measure Progress

### **Annual Benchmarks (vs. This Baseline):**

**2028 Checkpoint:**
- Portfolio should be $7.2M-$8.5M (conservative-to-base case)
- Roth conversions on track ($210K + $216K completed)
- Wells Fargo $1.7M-$1.85M remaining
- No forced selling during volatility

**2030 Mid-Point:**
- Portfolio should be $8.5M-$11M
- Roth conversions 60% complete ($860K of $1.35M)
- Wells Fargo $1.3M-$1.55M remaining
- Staying disciplined through market cycles

**2033 RMD Start:**
- Portfolio should be $10M-$14M
- Roth conversions 100% complete
- Bob's RMDs begin (age 73)
- Wells Fargo refills from excess RMDs

**2036 Target:**
- Portfolio $11.5M-$15M (conservative to bull case)
- **Median expectation: $12.8M**
- Wells Fargo stabilized at $1M+
- Legacy wealth for daughters maximized

### **Red Flags (Warning Signs):**

**Portfolio Level:**
- ğŸš© Underperforming base case by >15% for 2+ consecutive years
- ğŸš© Volatility exceeding 25% (materially higher than 17% expectation)
- ğŸš© Wells Fargo depleting faster than projected (forced selling risk)
- ğŸš© Unable to maintain time commitment (28-36 hrs/year)

**Theme Level:**
- ğŸš© Tech: Correlation to S&P 500 rises above 0.95 (losing diversification)
- ğŸš© Infrastructure: Power demand growth <100% through 2030 (thesis weakening)
- ğŸš© Longevity: GLP-1 drugs face regulatory ban or safety issues (thesis broken)

**Behavioral Level:**
- ğŸš© Panic selling during corrections (emotional decision-making)
- ğŸš© Chasing performance (buying high, selling low)
- ğŸš© Ignoring discipline (not rebalancing when needed)
- ğŸš© Losing conviction (second-guessing strategy constantly)

**If red flags appear:** Pause, pressure test assumptions, adjust intelligently (not emotionally).

---

## XIII. Estate Planning Integration

### **Trust Structure (Established):**
- **Bob & Susan Family Trust** (Joint Revocable)
- **Lifetime Heritage Trusts** for two daughters (upon death)
- **See-Through Conduit** language (IRA 10-year stretch compliance)
- **Asset protection** from divorce, creditors, lawsuits

### **Beneficiary Designations:**

**Primary Beneficiaries (All Accounts):**
- Bob's Roth IRA â†’ The Bob & Susan Family Trust
- Bob's Traditional IRA â†’ The Bob & Susan Family Trust
- eTrade IRA â†’ The Bob & Susan Family Trust
- Susan's IRA â†’ The Bob & Susan Family Trust
- Wells Fargo â†’ The Bob & Susan Family Trust

**Successor Trustees:**
- Primary: Daughter A
- Secondary: Daughter B

### **Inheritance Timeline (If Bob/Susan Live to 85+):**

**2045 (Bob 85, Susan 95):**
- Estate passes to daughters via Family Trust
- Assets flow into Lifetime Heritage Trusts (asset protection)
- 10-year stretch begins for inherited IRAs

**Projected Inheritance Values (2045):**
- Bob's Roth IRA: $8,500,000+ (100% tax-free, 30 years compounding)
- eTrade IRA: $5,200,000 (taxable over 10-year stretch)
- Susan's IRA: $2,100,000 (taxable over 10-year stretch)
- Traditional IRA Residual: $800,000 (taxable)
- Wells Fargo Residual: $500,000 (taxable)
- Lake Murray Estate: $3,400,000 equity (step-up basis)
- **Total Gross: ~$20,500,000**

**After-Tax Net to Daughters:**
- Roth: $8.5M (tax-free)
- Taxable IRAs: $8.1M â†’ $6.6M after taxes (10-year stretch optimization)
- Real estate: $3.4M (step-up basis, minimal tax)
- **Net Inheritance: ~$18.5M in protected trusts**

### **Tax Optimization for Daughters:**

**10-Year Stretch Strategy:**
- Years 1-3: Withdraw Roth only (tax-free, invest proceeds)
- Years 4-10: Distribute Traditional/eTrade across lower tax brackets
- Result: Minimize taxes, maximize after-tax inheritance

**Why This Matters:**
- Bob/Susan paid 24% on Roth conversions (2027-2032)
- Daughters avoid 32-37% brackets via smooth distributions
- **Tax savings: $800K-$1.2M vs. lump sum withdrawal**

---

## XIV. Document Control & Version History

### **Version Information:**

**Version:** 1.0 - BASELINE
**Date Created:** December 28, 2025
**Status:** Official Baseline for 2026 Pressure Testing
**Next Review:** March 31, 2026 (Q1 2026 pressure test)

**Purpose:**
This document preserves the December 2025 portfolio strategy as the official baseline for:
- Quarterly pressure testing throughout 2026
- Annual performance reviews
- Strategic adjustments based on evidence
- Maintaining long-term discipline

**Related Documents:**
- [MASTER-PORTFOLIO-STRATEGY-2025-12-28.md](MASTER-PORTFOLIO-STRATEGY-2025-12-28.md) - Full strategy details
- [Alternative-1-Deep-Dive-Stock-Analysis.md](CIO Portfolio Strategy/Alternative-1-Deep-Dive-Stock-Analysis.md) - Tech theme analysis
- [Energy-Infrastructure-AI-Thesis-Analysis.md](Energy-Infrastructure-AI-Thesis-Analysis.md) - Infrastructure theme
- [Longevity-Healthspan-Investment-Analysis.md](Longevity-Healthspan-Investment-Analysis.md) - Longevity theme
- All quarterly pressure test documents (to be created in 2026)

### **Change Log:**

**December 28, 2025:**
- Initial baseline document created
- All account allocations finalized
- 34-position portfolio established
- Pressure testing framework defined

**Future Updates:**
- Q1 2026 (March 31): First pressure test results
- Q2 2026 (June 30): DCA completion, H1 review
- Q3 2026 (September 30): Pre-2027 conversion review
- Q4 2026 (December 31): Annual review, 2027 planning

---

## XV. Closing Statement

### **What This Baseline Represents**

This is NOT a "set and forget" plan. It is a **living strategy** based on:
- Three secular theme convictions (tech, infrastructure, longevity)
- 30-year investment horizon with tax-free Roth compounding
- Evidence-based decision-making (not emotional reactions)
- Quarterly pressure testing to validate or adjust assumptions
- Intelligent adaptation as markets evolve

### **The Core Principles (Never Change These)**

1. **Wells Fargo is non-negotiable** - $1.97M liquidity buffer prevents forced selling
2. **Tax optimization matters** - Roth conversions at 24% save daughters $800K-$1.2M
3. **Theme diversification** - Multiple uncorrelated growth drivers reduce volatility
4. **Discipline over emotion** - Hold through corrections, rebalance intelligently
5. **Time is the advantage** - 30-year horizon allows tax-free compounding to work

### **What Will Change (And That's Okay)**

- **Specific allocations** may adjust based on valuations and fundamentals
- **Theme weightings** may shift if thesis strengthens or weakens
- **Individual stocks** may be replaced if better alternatives emerge
- **Risk levels** may be dialed up or down based on age/circumstances

**But the core strategy remains:** Maximize wealth creation for daughters through tax-optimized, theme-diversified, long-term investing with disciplined risk management.

---

## XVI. 2026 Pressure Testing Schedule

### **Quarterly Review Dates:**

| Quarter | Review Date | Focus | Action Items |
|:--------|:------------|:------|:-------------|
| **Q1 2026** | March 31, 2026 | Theme validation, 3-month performance | Document pressure test results |
| **Q2 2026** | June 30, 2026 | DCA completion, 6-month performance | Verify full deployment, rebalancing check |
| **Q3 2026** | September 30, 2026 | Retirement transition, pre-2027 planning | Bob retires June 2026, prepare for 2027 conversion |
| **Q4 2026** | December 31, 2026 | Annual review, 2027 conversion calculation | Calculate exact 2027 conversion, annual rebalancing |

### **Between Reviews:**

- **Monthly:** Monitor Wells Fargo spending (should decline ~$16K/month)
- **Monthly:** Track DCA deployment progress (6-month schedule)
- **As needed:** Respond to major market events (corrections, geopolitical shocks)
- **Daily:** Resist urge to over-monitor (checking prices daily creates anxiety)

### **2027 Launch Readiness:**

**December 2026 Final Checklist:**
- [ ] IRS 2027 brackets announced (calculate exact conversion amount)
- [ ] CPA consultation scheduled (quarterly estimated payments)
- [ ] All accounts verified and ready (balances, beneficiaries, access)
- [ ] Susan aligned on strategy (final sign-off)
- [ ] Wells Fargo confirmed â‰¥$1.97M
- [ ] Limit orders set for January purchases
- [ ] **Ready to execute January 6, 2027**

---

**This baseline strategy represents the culmination of comprehensive analysis across tech, infrastructure, and longevity themes, optimized for Bob & Susan's 30-year legacy wealth creation goal.**

**Next milestone: Q1 2026 Pressure Test (March 31, 2026)**

---

**END OF DECEMBER 2025 BASELINE STRATEGY DOCUMENT**
